United Therapeutics (UTHR) EBIT (2009 - 2026)
United Therapeutics' EBIT came in at $330.8 million for Q2 2026, down 9.2% from $364.5 million a year earlier but up 1.5% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) EBIT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, United Therapeutics reported EBIT of $1.4 billion, down 3.2% year-over-year; for FY2025, it came in at $1.49 billion, up 8.4% from FY2024.
- EBIT has increased in each of the last four years, with a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
- Going back by year, EBIT was $1.38 billion in FY2024 (+16.2%), $1.18 billion in FY2023 (+20.9%), $979.7 million in FY2022 (+76.2%) and $555.9 million in FY2021 (-6.4%).
- The five-year range for quarterly EBIT is $169.8 million (Q4 2021) to $388.5 million (Q3 2025).
- Year-over-year, EBIT has declined for three consecutive quarters, with growth averaging 6.6% over the last eight quarters.
- The fastest year-over-year change in EBIT over five years came in Q4 2021 (growth of 160.0%), and the weakest in Q1 2026 (a decline of 14.9%).
- Business Quant data shows UTHR's EBIT at $325.8 million (Q1 2026), $356.7 million (Q4 2025) and $388.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | United Therapeutics | 20.55 Bn | 10.04 Bn | 683.80 Mn | 330.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 330.80 Mn |
| Mar 31, 2026 | 325.80 Mn |
| Dec 31, 2025 | 356.70 Mn |
| Sep 30, 2025 | 388.50 Mn |
| Jun 30, 2025 | 364.50 Mn |
| Mar 31, 2025 | 382.80 Mn |
| Dec 31, 2024 | 357.70 Mn |
| Sep 30, 2024 | 343.10 Mn |
| Jun 30, 2024 | 319.90 Mn |
| Mar 31, 2024 | 356.30 Mn |
| Dec 31, 2023 | 260.10 Mn |
| Sep 30, 2023 | 327.00 Mn |
| Jun 30, 2023 | 313.40 Mn |
| Mar 31, 2023 | 284.40 Mn |
| Dec 31, 2022 | 175.60 Mn |
| Sep 30, 2022 | 314.30 Mn |
| Jun 30, 2022 | 201.80 Mn |
| Mar 31, 2022 | 288.00 Mn |
| Dec 31, 2021 | 169.80 Mn |
| Sep 30, 2021 | 228.70 Mn |
API Access
United Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();